Press release
Cystinosis Market Set to Grow Substantially Through 2034, DelveInsight Projects | Horizon Pharma, Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharma, Nacuity Pharma, Avrobio
DelveInsight's "Cystinosis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology as well as the Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Cystinosis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Cystinosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cystinosis Market Forecast
https://www.delveinsight.com/sample-request/cystinosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Cystinosis Market Report:
• The Cystinosis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In 2023, the total number of prevalent Cystinosis cases in the United States was estimated to be around 1,300.
• In 2023, the total prevalent population of Cystinosis in the EU4 countries and the UK was estimated at approximately 1,600 cases, while Japan had around 55 prevalent cases during the same year.
• In 2023, the United States reported the highest number of diagnosed prevalent cases of cystinosis, with around 680 cases. Within the EU4 and the UK, the UK had the most cases, followed by Germany, France, and Spain, while Italy had the fewest.
• In the 7MM, there were an estimated 1,250 cases of infantile nephropathic cystinosis, 65 cases of juvenile nephropathic cystinosis, and 45 cases of adult-onset (ocular or non-nephropathic) cystinosis.
• Key Cystinosis Companies: Horizon Pharmaceutical/Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharmaceuticals, Inc., Nacuity Pharmaceuticals, Avrobio, and others
• Key Cystinosis Therapies: PROCYSBI (cysteamine bitartrate), CYSTADROPS (cysteamine hydrochloride), NPI-001, N-Acetylcysteine Amide, RP103, AVR-RD-04 (CTNS-RD-04), and others
Cystinosis Overview
Cystinosis is a rare genetic disorder characterized by the accumulation of cystine, an amino acid, within cells. This buildup occurs because the lysosomes, which are responsible for breaking down and recycling cellular materials, cannot properly transport cystine out of the cell. Over time, the excessive cystine forms crystals that can damage various organs and tissues, particularly the kidneys and eyes.
Get a Free sample for the Cystinosis Market Report:
https://www.delveinsight.com/report-store/cystinosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cystinosis Market
The dynamics of the Cystinosis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2020-2034.
"There is only one upcoming therapy AVR-RD04 (Gene therapy) till date in the Cystinosis pipeline, to assess the long-term safety and durability of AVR-RD-04 treatment in participants who received a single dose administration of lentiviral gene therapy and will further decrease the market share of both the drugs."
Cystinosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cystinosis Epidemiology Segmentation:
The Cystinosis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Cystinosis
• Prevalent Cases of Cystinosis by severity
• Gender-specific Prevalence of Cystinosis
• Diagnosed Cases of Episodic and Chronic Cystinosis
Download the report to understand which factors are driving Cystinosis epidemiology trends @ Cystinosis Epidemiological Insights
https://www.delveinsight.com/sample-request/cystinosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cystinosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cystinosis market or expected to get launched during the study period. The analysis covers Cystinosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cystinosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Cystinosis Therapies and Key Companies
• PROCYSBI (cysteamine bitartrate) : Horizon Pharmaceutical/Chiesi Farmaceutici
• CYSTADROPS (cysteamine hydrochloride) : Recordati S.p.A
• NPI-001 : Nacuity Pharmaceuticals, Inc.
• N-Acetylcysteine Amide: Nacuity Pharmaceuticals
• RP103: Horizon Pharma USA
• AVR-RD-04 (CTNS-RD-04): Avrobio
To know more about Cystinosis treatment, visit @ Cystinosis Medications
https://www.delveinsight.com/sample-request/cystinosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cystinosis Market Drivers
• Advancement in technology
• Development of Biomarkers
• Gene therapy can improve the treatment
• Development of a new delivery system
• New symptomatic findings
Cystinosis Market Barriers
• Limited treatment option is available
• Lack of emerging pipeline
• Lack of disease understanding
• Challenges with the current therapies
Scope of the Cystinosis Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Cystinosis Companies: Horizon Pharmaceutical/Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharmaceuticals, Inc., Nacuity Pharmaceuticals, Avrobio, and others
• Key Cystinosis Therapies: PROCYSBI (cysteamine bitartrate), CYSTADROPS (cysteamine hydrochloride), NPI-001, N-Acetylcysteine Amide, RP103, AVR-RD-04 (CTNS-RD-04), and others
• Cystinosis Therapeutic Assessment: Cystinosis current marketed and Cystinosis emerging therapies
• Cystinosis Market Dynamics: Cystinosis market drivers and Cystinosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Cystinosis Unmet Needs, KOL's views, Analyst's views, Cystinosis Market Access and Reimbursement
Discover more about therapies set to grab major Cystinosis market share @ Cystinosis Treatment Landscape
https://www.delveinsight.com/sample-request/cystinosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Cystinosis Market Report Introduction
2. Executive Summary for Cystinosis
3. SWOT analysis of Cystinosis
4. Cystinosis Patient Share (%) Overview at a Glance
5. Cystinosis Market Overview at a Glance
6. Cystinosis Disease Background and Overview
7. Cystinosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Cystinosis
9. Cystinosis Current Treatment and Medical Practices
10. Cystinosis Unmet Needs
11. Cystinosis Emerging Therapies
12. Cystinosis Market Outlook
13. Country-Wise Cystinosis Market Analysis (2020-2034)
14. Cystinosis Market Access and Reimbursement of Therapies
15. Cystinosis Market Drivers
16. Cystinosis Market Barriers
17. Cystinosis Appendix
18. Cystinosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Cystinosis Pipeline https://www.delveinsight.com/report-store/cystinosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Cystinosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Cystinosis market. A detailed picture of the Cystinosis pipeline landscape is provided, which includes the disease overview and Cystinosis treatment guidelines.
Cystinosis Epidemiology https://www.delveinsight.com/report-store/cystinosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Cystinosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cystinosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
• Amblyopia Market: https://www.delveinsight.com/report-store/amblyopia-market
• Type 2 Diabetes Market: https://www.delveinsight.com/report-store/diabetes-market
• Parp Poly Adp-ribose Polymerase Inhibitor Market: https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight
• Erectile Dysfunction Market: https://www.delveinsight.com/report-store/erectile-dysfunction-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market
• Arteriovenous Malformations Market: https://www.delveinsight.com/report-store/vascular-malformations-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cystinosis Market Set to Grow Substantially Through 2034, DelveInsight Projects | Horizon Pharma, Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharma, Nacuity Pharma, Avrobio here
News-ID: 3842937 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Cystinosis
Cystinosis Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Cystinosis is a rare, inherited lysosomal storage disorder caused by the accumulation of cystine within cells, leading to progressive damage to multiple organs, including the kidneys, eyes, muscles, pancreas, and thyroid. If left untreated, it results in renal Fanconi syndrome, growth retardation, photophobia, and eventually kidney failure. The disease is typically diagnosed in infancy or early childhood, and without intervention, life expectancy is severely reduced.
Over the past two decades, cysteamine-based…
Nephropathic Cystinosis Treatment Market Surges with Innovative Drug Development …
The Nephropathic Cystinosis Treatment Market sector is undergoing significant transformation, with substantial growth and technological advancements expected by 2031. According to a new in-depth market research report, the sector is poised for expansion, driven by various factors such as market size, share, and emerging trends.
This comprehensive report provides key insights into the Nephropathic Cystinosis Treatment market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering…
Global Cystinosis Treatment Market Share Analysis - Industry Trends and Forecast …
Cystinosis Treatment Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Cystinosis Treatment Market Scope: Unveiling Today's Trends
Cystinosis Treatment involves therapies aimed at managing a rare genetic disorder characterized by the accumulation of cystine within cells. The market for Cystinosis Treatment has experienced significant advancements, with an increasing focus on innovative therapies and diagnostics. The rise in awareness about this rare condition, coupled with ongoing research and development activities, has propelled…
Nephropathic Cystinosis Treatment Market Size & Share Analysis - Growth Trends & …
Nephropathic Cystinosis Treatment Market Snapshot: Insight into Market Trends and Movements
Nephropathic cystinosis treatment primarily involves cystine-depleting therapy using cysteamine, alongside supportive measures for kidney function and managing complications.
The Nephropathic Cystinosis Treatment Market is experiencing significant growth due to rising awareness, advancements in drug formulations, and increased diagnostic capabilities. Patients' needs for innovative therapies drive market expansion, especially as research continues to uncover new treatment options. The introduction of cystine-depleting…
Nephropathic Cystinosis Treatment Market: A Comprehensive Analysis
The Nephropathic Cystinosis Treatment Market has witnessed significant growth in recent years, driven by advancements in research, therapeutic approaches, and a growing emphasis on multidisciplinary patient care. This article provides a comprehensive analysis of the market, encompassing market size, growth trends, key players, competitive landscape, consumer behavior, emerging technologies, regulatory environment, and future outlook.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) -…
Nephropathic Cystinosis Treatment Market Size to Cross USD 263 Mn by 2027
The latest research study released by Transparency Market Research on "Nephropathic Cystinosis Treatment Market Forecast to 2023-2027 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Nephropathic Cystinosis Treatment industry, as…
